Larger VC Deals Could Become More Common In Devices
This article was originally published in Start Up
You may also be interested in...
Device/Diagnostics Quarterly Deal Statistics, Q1 2012
Medical device companies raised $1.1 billion, a 40% increase over Q4 2011’s $800 million. Two billion-dollar deals in the resuscitation market boosted device acquisition activity to $4.2 billion. Twenty diagnostics financings brought in a collective $302 million, soaring above the previous quarter’s $269 million. There were seven diagnostics M&A deals completed, totaling $589 million – down yet again.
ConforMIS Gets Personal With $89 Million Round
ConforMIS last month closed on an $89 million Series E round to help pay for the company’s commercial launch of iTotal, customized, patient-specific total knee implants.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.